Literature DB >> 18455537

Quality of life and surgical satisfaction after vaginal reconstructive vs obliterative surgery for the treatment of advanced pelvic organ prolapse.

Miles Murphy1, Gina Sternschuss, Robin Haff, Heather van Raalte, Stephanie Saltz, Vincent Lucente.   

Abstract

OBJECTIVE: We sought to compare quality of life and patient satisfaction after obliterative vs reconstructive surgery. STUDY
DESIGN: A retrospective cohort study of women who met the following inclusion criteria: age 65 years or older, leading edge of prolapse 4 cm or greater beyond the hymen, and vaginal reconstructive or obliterative surgery. Preoperative responses to the Urogenital Distress Inventory (UDI-6) and Incontinence Impact Questionnaire (IIQ-7) were collected retrospectively. We then mailed the same questionnaires, and the Surgical Satisfaction Questionnaire (SSQ-8), to these subjects postoperatively.
RESULTS: Mode of surgery was evenly split (n = 45 per group) between the 90 patients meeting the inclusion criteria. Improvements from the preoperative to postoperative Incontinence Impact Questionnaire and Urogenital Distress Inventory were comparable as were postoperative Surgical Satisfaction Questionnaire scores.
CONCLUSION: Improvements in condition-specific quality of life and postoperative patient satisfaction measures are comparable in women with prolapse who undergo either reconstructive or obliterative surgery.

Entities:  

Mesh:

Year:  2008        PMID: 18455537     DOI: 10.1016/j.ajog.2007.12.036

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  15 in total

1.  Minimal mesh repair for apical and anterior prolapse: initial anatomical and subjective outcomes.

Authors:  Manhan K Vu; Juraj Letko; Kelly Jirschele; Adam Gafni-Kane; Aimee Nguyen; Honyan Du; Roger P Goldberg
Journal:  Int Urogynecol J       Date:  2012-04-25       Impact factor: 2.894

2.  Symptom importance, patient expectations, and satisfaction in chronic rhinosinusitis.

Authors:  Jose L Mattos; Luke Rudmik; Rodney J Schlosser; Timothy L Smith; Jess C Mace; Jeremiah Alt; Zachary M Soler
Journal:  Int Forum Allergy Rhinol       Date:  2019-02-12       Impact factor: 3.858

3.  The underutilization of obliterative and constrictive surgery in the surgical treatment of pelvic organ prolapse.

Authors:  Tony Bazi
Journal:  Int Urogynecol J       Date:  2019-06-10       Impact factor: 2.894

4.  Laparoscopic sacrocolpopexy versus transvaginal mesh for recurrent pelvic organ prolapse.

Authors:  Cheryl B Iglesia; Douglass S Hale; Vincent R Lucente
Journal:  Int Urogynecol J       Date:  2012-08-29       Impact factor: 2.894

5.  Prospective study of an ultra-lightweight polypropylene Y mesh for robotic sacrocolpopexy.

Authors:  Charbel G Salamon; Christa Lewis; Jennifer Priestley; Emil Gurshumov; Patrick J Culligan
Journal:  Int Urogynecol J       Date:  2013-01-08       Impact factor: 2.894

6.  Quality of life following vaginal reconstructive versus obliterative surgery for treating advanced pelvic organ prolapse.

Authors:  Alin Petcharopas; Supreeya Wongtra-Ngan; Orawee Chinthakanan
Journal:  Int Urogynecol J       Date:  2018-01-27       Impact factor: 2.894

Review 7.  Apical prolapse.

Authors:  Matthew D Barber; Christopher Maher
Journal:  Int Urogynecol J       Date:  2013-11       Impact factor: 2.894

8.  Subjective and objective outcomes 1 year after robotic-assisted laparoscopic sacrocolpopexy.

Authors:  Charbel G Salamon; Patrick J Culligan
Journal:  J Robot Surg       Date:  2012-02-10

9.  Patient surgical satisfaction after da Vinci® single-port and multi-port robotic-assisted radical prostatectomy: propensity score-matched analysis.

Authors:  Jonathan Noël; Marcio Covas Moschovas; Marco Sandri; Seetharam Bhat; Travis Rogers; Sunil Reddy; Cathy Corder; Vipul Patel
Journal:  J Robot Surg       Date:  2021-06-18

10.  Subjective and objective results 1 year after robotic sacrocolpopexy using a lightweight Y-mesh.

Authors:  Patrick J Culligan; Emil Gurshumov; Christa Lewis; Jennifer L Priestley; Jodie Komar; Nihar Shah; Charbel G Salamon
Journal:  Int Urogynecol J       Date:  2013-11-22       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.